ArticleBMC cancer2020

Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma.

Travers Ching et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.